Publications

Total Articles 29
Books 0
Proceedings 0

Publications

No publication activity to display at the moment.

Scopus

Citations 477
h-index 14

CrossRef

CrossRef Icon
Citations 218
h-index 10
Google Scholar

Loading Scholar statistics...

Professional Recognition

2023

Research Excellence Award

Institute of Scholars (InSc), under Ministry of MSME & Corporate Affairs, Govt. of India
2022

Best Oral Presentation

Indian Association of Biomedical Scientists
2019

Senior Research Fellowship

Indian Council of Medical Research

Community & Membership

No Data Found

There is currently nothing to display here.

International Association of Oncology

2021
Student Member

American Association for Cancer Research

2020
Associate Member

Manipal-Government of Karnataka Bioincubator

2020
Life Member

Indian Association of Cancer Research

2019
Life Member

New Zealand Association of Breast Cancer Research

2019
Member

Bio

I am a highly motivated, hard-working, and responsible biomedical researcher aiming to conduct cancer research and develop novel and improved anti-cancer therapeutics. During my doctoral research at KIIT University, I worked on the development of a chemotherapeutic regimen to target breast cancer cells by inducing DNA damage and simultaneously inhibiting the DNA repair pathways. I used in vitro, ex vivo and in vivo pre-clinical model systems to address my research questions.

Personal Details

  • Male
  • KIIT Deemed to be University
Ph.D.
KIIT Deemed to be University, Bhubaneswar 2024
Postgraduate Diploma in Science
Other Institute 2016
Master of Science
Bangalore University 2013
Bachelor of Science
Bangalore University 2009
Research Scholar Jul 2020 – Sep 2024
KIIT Deemed to be University, Bhubaneswar | School of Biotechnology
Senior Research Fellow Jul 2019 – Jul 2022
KIIT Deemed to be University, Bhubaneswar | School of Biotechnology
Project Assistant Sep 2018 – Mar 2019
KIIT Deemed to be University, Bhubaneswar | School of Biotechnology

Related Profiles

Experts (181+)

View All
Abhishek

Mr Abhishek Agarwal

Assistant Professor

Preeti

Dr Preeti Sharma

Assistant Professor

Pavithra

Pavithra Velayutham

Assistant Professor

Mahaboob

Dr Mahaboob Basha

Physical Director

HIBA

HIBA -

Assistant Professor

Muskan

Dr Muskan Jain (PT)

Assistant Professor

Shalini

Ms Shalini Saini

Assistant Professor

Organisation (0)

no data

Co-Authors (4)

Chanakya Nath

Prof Chanakya Nath Kundu

Kalinga Institute of Industrial Technology, Bhubaneswar

Joydeb

Dr Joydeb Maji

SILIGURI COLLEGE, DARJEELING

Jasaswini

Dr Jasaswini Tripathy

Kalinga Institute of Industrial Technology, Bhubaneswar

Mahitosh

Prof Mahitosh Mandal

Indian Institute of Technology Kharagpur

Scholarly Work

No Data Found

There is currently nothing to display here.

No Data Found

There is currently nothing to display here.

No Data Found

There is currently nothing to display here.

Scholarly Publications

Nano formulated Resveratrol inhibits PD-L1 in oral cancer cells by deregulating the association between tumor associated macrophages and cancer associated fibroblasts through IL-6/JAK2/STAT3 signaling axis

Open Access
Article
Authors: Pradhan R.;Paul S.;Acharya S.S.;Sinha S.;Dash S.R.;Kundu C.N.

Combination of Resveratrol and PARP inhibitor Olaparib efficiently deregulates homologous recombination repair pathway in breast cancer cells through inhibition of TIP60-mediated chromatin relaxation

Open Access
Article
Authors: Sinha S.;Paul S.;Acharya S.S.;Das C.;Dash S.R.;Bhal S.;Pradhan R.;Das B.;Kundu C.N.

Near infrared-responsive quinacrine–gold hybrid nanoparticles deregulate HSP-70/P300-mediated H3K14 acetylation in ER/PR+ breast cancer stem cells

Open Access
Article
Authors: Dash S.R.;Das C.;Das B.;Jena A.B.;Paul S.;Sinha S.;Tripathy J.;Kundu C.N.

Resveratrol nanoparticles induce apoptosis in oral cancer stem cells by disrupting the interaction between β-catenin and GLI-1 through p53-independent activation of p21

Open Access
Article
Authors: Bhal S.;Das B.;Sinha S.;Das C.;Acharya S.S.;Maji J.;Kundu C.N.

Targeting signaling pathways in cancer stem cells: A potential approach for developing novel anti-cancer therapeutics

Open Access
book-chapter

Talazoparib enhances the quinacrine-mediated apoptosis in patient-derived oral mucosa CSCs by inhibiting BER pathway through the modulation of GCN5 and P300

Open Access
Article
Authors: Das C.;Dash S.R.;Sinha S.;Paul S.;Das B.;Bhal S.;Sethy C.;Kundu C.N.

Veliparib (ABT-888), a PARP inhibitor potentiates the cytotoxic activity of 5-fluorouracil by inhibiting MMR pathway through deregulation of MSH6 in colorectal cancer stem cells

Open Access
Article
Authors: Paul S.;Chatterjee S.;Sinha S.;Dash S.R.;Pradhan R.;Das B.;Goutam K.;Kundu C.N.

Red Wine Polyphenol Resveratrol Reduces Breast Cancer Progression and PARP Inhibitor Olaparib Efficiently Enhances its Anti-cancer Action

Open Access
editorial
Authors: Sinha S, Kundu CN